Globus Medical (GMED) May Begin to See Indications Its Trauma Investment is Paying Off, PT to $58 at BTIG
Tweet Send to a Friend
BTIG analyst Ryan Zimmerman raised the price target on Globus Medical (NYSE: GMED) to $58.00 (from $53.00) on the belief ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
